Institute for Biomedicine - CHRIS and Research
CHRIS and Research
- English
- Italiano
Biomedical research can be represented as a cycle in which the population is both the starting point and the end point. Thanks to the participation of the population, biological samples, epidemiological and clinical data can be collected and studied by researchers in the laboratory. Research in the laboratory is a long phase that often also requires comparison with research institutes in other countries in order to confirm or complete the results obtained. Once confirmed, the scientific results are revised in order to formulate prevention-oriented public health programmes. With the implementation of these programmes, the data collected and the research carried out return to the population in the form of knowledge, allowing the health conditions of the population to be improved.
Research results
CHRIS is a dynamic platform for research: the data it collects and its results are a resource for conducting sub-studies aimed at investigating specific diseases or aspects of health. CHRIS therefore has a very relevant value for the international scientific community, with the ability to pave the way for more targeted research with a direct impact in terms of early diagnosis and treatment of diseases.
J Transl Med 2015 - Protocol paper
Hum Genet 2017 - Biochemical parameters
J Pain 2018 - Pain sensitivity questionnaire
PLoS ONE 2019 - Heart rate variability and smoking
Main publications
Acknowledgements
The CHRIS study is a collaborative effort between the Eurac Research Institute for Biomedicine and the Healthcare System of the Autonomous Province of Bozen/Bolzano (Südtiroler Sanitätsbetrieb/Azienda Sanitaria dell'Alto Adige). The CHRIS study is funded by the Department of Innovation, Research and University of the Autonomous Province of Bozen/Bolzano. The CHRIS Study is affiliated to the "German National Cohort" (Germany) and is indebted with the investigators of this study for their support in the study protocol definition. Investigators thank all study participants from the middle and upper Vinschgau/Val Venosta, the general practitioners, and the personnel of the Hospital of Schlanders/Silandro for their support and collaboration.
Extensive acknowledgement list is reported here.
Access to data and samples
The Institute for Biomedicine relies on a public regulation for allowing external access to data and samples in order to maximize use and allow better use of the resource. Requests will be evaluated by a multidisciplinary access committee. Reviews are public, and access is granted based on a Data Transfer Agreement or material transfer agreements (in case biosamples are requested).
CHRIS 2D
CHRIS is also successfully collaborating with companies operating in molecular diagnostics, food and telemedicine, demonstrating that population studies can become powerful tools for biotechnological industrial development. In this perspective CHRIS is also the starting point for the development of spin-off projects such as CHRIS-2D, a project that will involve private and public stakeholders through the establishment of a dynamic data portal linked to the database and biobank and managed by the CHRIS study governance system. The portal will foster visibility and interaction with users, who will be able to explore the data and devise innovative R&D projects. The iterative updating of the portal with new data generated by each approved project will ensure continuous expansion and uniqueness of the resource, which will thus attract new local and international investors. Go to the CHRIS 2D project page to learn more.